These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 18814144)
1. Modulation of mouse RANKL gene expression by Runx2 and vitamin D3. Kitazawa R; Mori K; Yamaguchi A; Kondo T; Kitazawa S J Cell Biochem; 2008 Dec; 105(5):1289-97. PubMed ID: 18814144 [TBL] [Abstract][Full Text] [Related]
2. Modulation of mouse RANKL gene expression by Runx2 and PKA pathway. Mori K; Kitazawa R; Kondo T; Maeda S; Yamaguchi A; Kitazawa S J Cell Biochem; 2006 Aug; 98(6):1629-44. PubMed ID: 16598781 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. Kitazawa S; Kajimoto K; Kondo T; Kitazawa R J Cell Biochem; 2003 Jul; 89(4):771-7. PubMed ID: 12858342 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. Kitazawa R; Kitazawa S Biochem Biophys Res Commun; 2002 Jan; 290(2):650-5. PubMed ID: 11785948 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic control of mouse receptor activator of NF-kappa B ligand gene expression. Kitazawa S; Kitazawa R Biochem Biophys Res Commun; 2002 Apr; 293(1):126-31. PubMed ID: 12054573 [TBL] [Abstract][Full Text] [Related]
6. Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts. Inada M; Tsukamoto K; Hirata M; Takita M; Nagasawa K; Miyaura C Biochem Biophys Res Commun; 2008 Aug; 372(3):434-9. PubMed ID: 18489902 [TBL] [Abstract][Full Text] [Related]
7. Methylation status of a single CpG locus 3 bases upstream of TATA-box of receptor activator of nuclear factor-kappaB ligand (RANKL) gene promoter modulates cell- and tissue-specific RANKL expression and osteoclastogenesis. Kitazawa R; Kitazawa S Mol Endocrinol; 2007 Jan; 21(1):148-58. PubMed ID: 17008384 [TBL] [Abstract][Full Text] [Related]
8. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines. Liu T; Gao Y; Sakamoto K; Minamizato T; Furukawa K; Tsukazaki T; Shibata Y; Bessho K; Komori T; Yamaguchi A J Cell Physiol; 2007 Jun; 211(3):728-35. PubMed ID: 17226753 [TBL] [Abstract][Full Text] [Related]
9. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional induction of matrix metalloproteinase-13 (collagenase-3) by 1alpha,25-dihydroxyvitamin D3 in mouse osteoblastic MC3T3-E1 cells. Uchida M; Shima M; Chikazu D; Fujieda A; Obara K; Suzuki H; Nagai Y; Yamato H; Kawaguchi H J Bone Miner Res; 2001 Feb; 16(2):221-30. PubMed ID: 11204422 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator. Tamiya H; Ikeda T; Jeong JH; Saito T; Yano F; Jung YK; Ohba S; Kawaguchi H; Chung UI; Choi JY Gene; 2008 Jun; 416(1-2):53-60. PubMed ID: 18442887 [TBL] [Abstract][Full Text] [Related]
12. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats. Charoenphandhu N; Teerapornpuntakit J; Methawasin M; Wongdee K; Thongchote K; Krishnamra N Can J Physiol Pharmacol; 2008 May; 86(5):240-8. PubMed ID: 18432284 [TBL] [Abstract][Full Text] [Related]
14. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand. Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866 [TBL] [Abstract][Full Text] [Related]
15. Response to mechanical strain in an immortalized pre-osteoblast cell is dependent on ERK1/2. Fan X; Rahnert JA; Murphy TC; Nanes MS; Greenfield EM; Rubin J J Cell Physiol; 2006 May; 207(2):454-60. PubMed ID: 16419041 [TBL] [Abstract][Full Text] [Related]
16. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1. Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057 [TBL] [Abstract][Full Text] [Related]
17. Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice. Onal M; St John HC; Danielson AL; Pike JW J Bone Miner Res; 2016 Feb; 31(2):416-29. PubMed ID: 26332516 [TBL] [Abstract][Full Text] [Related]
18. Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells. Fan X; Roy EM; Murphy TC; Nanes MS; Kim S; Pike JW; Rubin J J Cell Biochem; 2004 Nov; 93(4):807-18. PubMed ID: 15389882 [TBL] [Abstract][Full Text] [Related]
19. RUNX2 Mutation Impairs 1α,25-Dihydroxyvitamin D3 mediated Osteoclastogenesis in Dental Follicle Cells. Wang XZ; Sun XY; Zhang CY; Yang X; Yan WJ; Ge LH; Zheng SG Sci Rep; 2016 Apr; 6():24225. PubMed ID: 27068678 [TBL] [Abstract][Full Text] [Related]
20. Human estrogen receptor alpha gene is a target of Runx2 transcription factor in osteoblasts. Lambertini E; Penolazzi L; Tavanti E; Schincaglia GP; Zennaro M; Gambari R; Piva R Exp Cell Res; 2007 May; 313(8):1548-60. PubMed ID: 17350616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]